Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
TARA

Protara Therapeutics (TARA) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $2.75 +4.0% on the day -50.9% over 12 months 52-week range $2.56 – $7.56

Share price and insider trades

TARA closeInsider buyInsider sale
2468NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $6,124 on 2026-04-08 · Jacqueline ZummoSold $118,865 on 2026-04-01 · Jacqueline ZummoSold $882,160 on 2026-06-29 · Jesse Shefferman
Bought, 12 months$0
Sold, 12 months$1.0M
Insiders buying0
Insiders selling2

Protara Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $1.0M of TARA stock on the open market.

TARA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $1.0M sold (3 trades)Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0$1.0M3

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.2×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Protara Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $1.0M. 2 of 3 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jul 1SEC Jesse SheffermanCEO, President Sell 215,687721,832 held (−23%) $4.09 $882K -32.6% —
Apr 9SEC Jacqueline ZummoChief R&D Officer Sell Plan 1,13494,827 held (−1%) $5.40 $6K -49.0% —
Apr 2SEC Jacqueline ZummoChief R&D Officer Sell Plan 22,59895,961 held (−19%) $5.26 $119K -47.6% —

Insiders at Protara Therapeutics, Inc.

InsiderBoughtSoldLast filingScore
Jesse SheffermanCEO, President — $882K Jul 1, 2026 —
Jacqueline ZummoChief R&D Officer — $125K Apr 9, 2026 —

TARA stock: common questions

Are Protara Therapeutics, Inc. insiders buying TARA stock?

In the past 12 months, 0 insiders reported open-market purchases of TARA worth $0.

Are Protara Therapeutics, Inc. insiders selling TARA stock?

2 insiders reported sales worth $1.0M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is TARA's 52-week range?

Over the past year TARA has traded between $2.56 and $7.56. It last closed at $2.75 on Oct 9, 2026.